Cara Tannenbaum

Last updated
Cara Tannenbaum
CM
Alma materMcGill University
Known forGender and Health
Scientific career
Fieldsgeriatrics, women's health and gender research
InstitutionsUniversité de Montréal

Cara Tannenbaum CM is a Canadian researcher and practicing physician in the fields of geriatrics, women's health, and gender research. Since 2015, Tannenbaum has served as the Scientific Director of Canadian Institutes of Health Research's Institute of Gender and Health. [1] [2] She was appointed as a Member of the Order of Canada on November 17, 2021. [3]

Contents

Career

Tannenbaum completed medical school (1994), additional training in geriatrics (2000), and a Master of Science degree in epidemiology and biostatistics (2002) at McGill University. [4] [5] [6] She is now a professor of medicine and pharmacy at the Université de Montréal, where she conducts research at the Centre de recherche de l’Institut universitaire de gériatrie de Montréal. [6] [2] [7] [8] In 2015, Tannenbaum was appointed Scientific Director of the Institute of Gender and Health at the Canadian Institutes of Health Research and was appointed Departmental Science Advisor for Health Canada in 2019. [9]

Research

Tannenbaum was initially involved in the EMPOWER (Eliminating Medications Through Patient Ownership of End Results) trial, which is an educational intervention (using a theory-based patient handout) to engage older adults with their pharmacist or physician in discontinuing inappropriate medication. [10] [11] The EMPOWER trial resulted in 27% of participants in the intervention group discontinuing their benzodiazepine use (compared with 5% of the control group) at six months. [8] [12] Through this trial, Tannenbaum and her colleagues found that two-thirds of individuals who received EMPOWER handouts had taken it to their doctor or pharmacist, but in about half of these instances, the health care professionals discouraged deprescribing. [8] This prompted Tannenbaum to launch and oversee the D-PRESCRIBE clinical trial, which tested whether a pharmacist-led educational intervention could decrease the number of prescriptions issued for inappropriate medication among 489 older adults in Quebec. [7] [13] [14] The trial found that a pharmacist intervention resulted in greater medication discontinuation (43%) at six months than those receiving regular care. [7] [13] [14]

Between May 2013 and July 2017, Tannenbaum led the international "Dare to Age Well for Women" urinary incontinence trial (also referred to as the CACTUS-D i.e. Continence Across Continents To Upend Stigma and Dependency), which was a randomised controlled trial to test the effect of a continence promotion intervention on the urinary symptoms and quality of life in 910 women, aged 65 or older, in the United Kingdom, France, and Canada (Alberta, Quebec). [15] [16] [17] So far, results from the women recruited from the UK indicate that participants in the combined intervention group had the highest rate of urinary symptom improvement, and that the recruitment rate for local community organizations was as high as 44%. [18] [19]

Tannenbaum co-founded the Canadian Deprescribing Network (CaDeN), and previously served as a co-director. [6]

During the COVID-19 pandemic, Tannenbaum has served on the Canada Chief Science Advisor's Expert Group on Health Systems, and helped lead the implementation efforts for CanCOVID, a Canada-wide network of over 3,000 health, science and policy researchers to facilitate COVID-19 research collaboration. [20] [21] [22] With Holly Witteman and Jenna Haverfield, Tannenbaum found that when the Canadian Institutes of Health Research implemented data-driven gender policy interventions in a second COVID-19 funding competition (April-May 2020), the funding competition received more grant applications from female scientists, and received and funded more grant applications which considered sex and gender in their study design. [23]

Tannenbaum has published over 200 academic publications, which have been cited over 6,500 times, resulting in a h-index and i10-index of 42 and 101 respectively. [24]

Awards, honours and public engagement

In 2018, Tannenbaum was inducted as a fellow of the Canadian Academy of Health Sciences. [25] [26] She has been awarded the Association of Faculties of Medicine of Canada's May-Cohen Gender Equity Award, the Canadian Institutes of Health Research's Betty Haven's Knowledge Transfer Prize in Aging, the Society of Chemical Industry Purvis Memorial Award (2020) and the American Society for Clinical Pharmacology & Therapeutics' William B. Abrams Awards in Geriatric Clinical Pharmacology (2021), and is the Michel-Saucier Endowed Chair in Geriatric Pharmacology, Health and Aging. [5] [2] [7] [27] [28] [29] [30] In 2020, Tannenbaum was awarded the Canadian Science Policy Centre's Exceptional Contribution to Science Policy Award: Trailblazer Award. [22]

On November 17, 2021, Tannenbaum was appointed as a Member of the Order of Canada for "her leadership in geriatrics, women’s health and gender research, and for her inter-professional collaborations to optimize healthy aging across the lifespan". [3] [31]

Tannenbaum has also written editorials regarding various issues related to her research expertise, including an editorial in The BMJ to address the International Association of Athletics Federations' new "differences of sex development" rules causing Caster Semenya to no longer be eligible, and why sex and gender matter in implementation research in the BMC Medical Research Methodology. [32] [33] [34] [35] [36]

Selected bibliography

Related Research Articles

<span class="mw-page-title-main">Canadian Institutes of Health Research</span> Canadian federal agency

The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.

The Faculty of Veterinary Medicine at Université de Montréal is one of five veterinary medical schools in Canada. It is the only French-language veterinary college in North America. The faculty is part of the Université de Montréal and is located in Saint-Hyacinthe, Quebec near Montreal.

<span class="mw-page-title-main">Clinical pharmacy</span> Branch of pharmacy for direct provision

Clinical pharmacy is the branch of pharmacy in which clinical pharmacists provide direct patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, physician assistants, nurse practitioners, and other healthcare professionals. Clinical pharmacists can enter into a formal collaborative practice agreement with another healthcare provider, generally one or more physicians, that allows pharmacists to prescribe medications and order laboratory tests.

<span class="mw-page-title-main">National Core for Neuroethics</span>

The National Core for Neuroethics at the University of British Columbia was established in August 2007, with support from the Canadian Institutes of Health Research, the Institute of Mental Health and Addiction, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the Canada Research Chairs program, the UBC Brain Research Centre and the UBC Institute of Mental Health. Co-founded by Judy Illes and Peter Reiner, the Core studies neuroethics, with particular focus on ethics in neurodegenerative disease and regenerative medicine, international and cross-cultural challenges in brain research, neuroimaging and ethics, the neuroethics of enhancement, and personalized medicine.

PubMed Central Canada was a Canadian national digital repository of peer-reviewed health and life sciences literature. It operated from 2010 to 2018. It joined Europe PubMed Central as a member of the PubMed Central International network. PMC Canada was a partnership between the Canadian Institutes of Health Research (CIHR), the Canada Institute for Scientific and Technical Information, and the United States National Library of Medicine (NLM).

Actua is a Canadian charitable organization that delivers science, engineering and technology educational programs to young people in Canada.

Aubrey Tingle is professor emeritus in the Department of Pediatrics at the University of British Columbia (UBC) and chair of the board of directors at the Maternal, Infant, Child and Youth Research Network. In March 2001, Tingle was appointed the first president and CEO of The Michael Smith Foundation for Health Research (MSFHR).

<span class="mw-page-title-main">Deprescribing</span> Process to taper or stop medications

Deprescribing is a process of tapering or stopping medications to achieve improved health outcomes by reducing exposure to medications that are potentially either harmful or no longer required. Deprescribing is important to consider with changing health and care goals over time, as well as polypharmacy and adverse effects. Deprescribing can improve adherence, cost, and health outcomes but may have adverse drug withdrawal effects. More specifically, deprescribing is the planned and supervised process of intentionally stopping a medication or reducing its dose to improve the person's health or reduce the risk of adverse side effects. Deprescribing is usually done because the drug may be causing harm, may no longer be helping the patient, or may be inappropriate for the individual patient's current situation. Deprescribing can help correct polypharmacy and prescription cascade.

Éric A. Cohen is a Canadian molecular virologist whose research is focused on human immunodeficiency virus (HIV)-host interactions that govern viral replication and persistence.

B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.

Gillian Einstein is a faculty member at the Dalla Lana School of Public Health and the Department of Psychology at the University of Toronto, and holder of the inaugural Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging.

<span class="mw-page-title-main">Bryn Williams-Jones</span> Canadian bioethicist (born 1972)

Bryn Williams-Jones is a Canadian bioethicist, professor and director of the Department of Social and Preventive Medicine at the School of Public Health, Université de Montréal. He is co-founder and editor-in-chief of the Canadian Journal of Bioethics/Revue canadienne de bioéthique, the first open access bilingual bioethics journal in Canada, and co-director of the Ethics branch of the International Observatory on the Social Impact of AI and Digital Technology (OBVIA). Williams-Jones is a member of the Centre for Research in Public Health (CReSP), the Centre for Ethics Research (CRÉ), the Institute for Applied Ethics (IDÉA) of the Université Laval, and fellow of The Hastings Center.

The Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria supports clinicians to manage medication use specifically for people with dementia without focusing only on the management of the dementia itself.

Elham Emami is an Iranian-Canadian clinician scientist. She is the dean of McGill University Dental Medicine and Oral Health Sciences. Born and raised in Iran, Emami moved to Canada in 2002 to pursue her PhD and MSc at the Université de Montréal.

Paul J. Allison is a Canadian clinician scientist and oral surgeon. He is the immediate former dean of the McGill University Faculty of Dentistry and is the current president of the Canadian Academy of Health Sciences.

Holly Witteman is a health informatics researcher. She is a Full Professor in the Department of Family & Emergency Medicine at the Université Laval, in Quebec City, Canada. Witteman is the Canada Research Chair in Human-Centred Digital Health.

Anne Monique Nuyt is a Canadian paediatrician who is Professor of Neonatology and Canada Research Chair in Prematurity and Developmental Origins of Cardiovascular Health and Diseases at the Université de Montréal. Her research considers how perinatal oxidative stress can alter the structural development and function of the cardiovascular system.

<span class="mw-page-title-main">Peter Tugwell</span> Canadian physician working on health equity

Peter Tugwell is a Canadian physician and Professor in the Department of Medicine and School of Epidemiology and Public Health at the University of Ottawa. He is known for promoting clinical epidemiology and championing for health equity worldwide. In 2013 he was named Officer of the Order of Canada for his efforts as "tireless contributor to global health".

Philip James Devereaux is a Canadian cardiologist, clinical epidemiologist, and perioperative care physician. Devereaux conducts clinical research within cardiac and perioperative fields, with a focus on vascular surgical complications.

References

  1. ↑ "Cara Tannenbaum nommée directrice scientifique de l'Institut de la santé des femmes et des hommes des IRSC - Faculté de médecine - Université de Montréal". Faculté de médecine (in French). 2014-11-18. Retrieved 2020-01-04.
  2. 1 2 3 Government of Canada, Canadian Institutes of Health Research (2011-06-29). "Biography – IGH Scientific Director: Dr. Cara Tannenbaum - CIHR". cihr-irsc.gc.ca. Retrieved 2020-01-04.
  3. 1 2 General, Office of the Secretary to the Governor (2021-12-20). "Governor General announces 135 new appointments to the Order of Canada". The Governor General of Canada. Retrieved 2022-01-08.
  4. ↑ "Researcher". La recherche - Université de Montréal. Retrieved 2020-01-04.
  5. 1 2 "Cara Tannenbaum : oser vieillir en santé - Faculté de médecine - Université de Montréal". Faculté de médecine (in French). Retrieved 2020-01-04.
  6. 1 2 3 "Tannenbaum Cara". CRIUGM. Retrieved 2022-01-08.
  7. 1 2 3 4 "Want to cut down on your meds? Your pharmacist can help". nouvelles.umontreal.ca. 2019-07-15. Archived from the original on 2019-01-31. Retrieved 2020-01-04.
  8. 1 2 3 Pike, Harriet. "Deprescribing: the fightback against polypharmacy has begun". The Pharmaceutical Journal. Archived from the original on 2020-09-10. Retrieved 2020-01-04.
  9. ↑ Government of Canada, Canadian Institutes of Health Research (2011-06-29). "Biography – IGH Scientific Director: Dr. Cara Tannenbaum - CIHR". cihr-irsc.gc.ca. Retrieved 2022-01-08.
  10. ↑ "An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2020-01-04.
  11. ↑ Martin, Philippe; Tannenbaum, Cara (2017-04-01). "A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial". BMJ Open. 7 (4): e015959. doi:10.1136/bmjopen-2017-015959. ISSN   2044-6055. PMC   5566584 . PMID   28473524.
  12. ↑ Tannenbaum, Cara; Martin, Philippe; Tamblyn, Robyn; Benedetti, Andrea; Ahmed, Sara (2014-06-01). "Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education: The EMPOWER Cluster Randomized Trial". JAMA Internal Medicine. 174 (6): 890–898. doi: 10.1001/jamainternmed.2014.949 . ISSN   2168-6106. PMID   24733354.
  13. 1 2 Martin, Philippe; Tamblyn, Robyn; Benedetti, Andrea; Ahmed, Sara; Tannenbaum, Cara (2018-11-13). "Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial". JAMA. 320 (18): 1889–1898. doi: 10.1001/jama.2018.16131 . ISSN   0098-7484. PMC   6248132 . PMID   30422193.
  14. 1 2 Carroll, Aaron E. (2019-01-28). "The Unsung Role of the Pharmacist in Patient Health". The New York Times. ISSN   0362-4331 . Retrieved 2020-01-04.
  15. ↑ "Continence Across Continents to Upend Stigma and Dependency - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2020-01-04.
  16. ↑ Tannenbaum, Cara; van den Heuvel, Eleanor; Fritel, Xavier; Southall, Kenneth; Jutai, Jeffrey; Rajabali, Saima; Wagg, Adrian (December 2015). "Continence Across Continents To Upend Stigma and Dependency (CACTUS-D): study protocol for a cluster randomized controlled trial". Trials. 16 (1): 565. doi: 10.1186/s13063-015-1099-x . ISSN   1745-6215. PMC   4676178 . PMID   26652168.
  17. ↑ "Cara Tannenbaum et Jean-Pierre Gagné au cœur des six projets 2012 retenus par l'ERA-AGE - École d'orthophonie et d'audiologie - Université de Montréal". École d'orthophonie et d'audiologie (in French). 2012-11-08. Retrieved 2020-01-04.
  18. ↑ Tannenbaum, Cara; Agnew, Rona; Benedetti, Andrea; Thomas, Doneal; van den Heuvel, Eleanor (December 2013). "Effectiveness of continence promotion for older women via community organisations: a cluster randomised trial". BMJ Open. 3 (12): e004135. doi:10.1136/bmjopen-2013-004135. ISSN   2044-6055. PMC   3863125 . PMID   24334159.
  19. ↑ Agnew, Rona; van den Heuvel, Eleanor; Tannenbaum, Cara (February 2013). "Efficiency of using community organisations as catalysts for recruitment to continence promotion trials". Clinical Trials: Journal of the Society for Clinical Trials. 10 (1): 151–159. doi:10.1177/1740774512460144. ISSN   1740-7745. PMID   23043154. S2CID   20884658.
  20. ↑ Government of Canada, Innovation. "Expert Group on Health Systems - Science.gc.ca". science.gc.ca. Retrieved 2022-01-08.
  21. ↑ Government of Canada, Innovation. "CanCOVID Network - Science.gc.ca". science.gc.ca. Retrieved 2022-01-08.
  22. 1 2 Digital, Rocket. "Trailblazer Award Winner". CSPC. Retrieved 2022-01-08.
  23. ↑ Witteman, Holly O.; Haverfield, Jenna; Tannenbaum, Cara (2021-02-09). "COVID-19 gender policy changes support female scientists and improve research quality". Proceedings of the National Academy of Sciences of the United States of America. 118 (6): e2023476118. Bibcode:2021PNAS..11820234W. doi: 10.1073/pnas.2023476118 . ISSN   0027-8424. PMC   8017703 . PMID   33531366.
  24. ↑ "Cara Tannenbaum". scholar.google.ca. Retrieved 2022-01-08.
  25. ↑ "CAHS Fellows Directory – Canadian Academy of Health Sciences" . Retrieved 2020-01-04.
  26. ↑ "Deux professeurs de l'UdeM entrent à l'Académie canadienne des sciences de la santé". nouvelles.umontreal.ca (in French). 2018-09-14. Archived from the original on 2020-11-23. Retrieved 2020-01-04.
  27. ↑ "Better care for women's health". Scientifique en chef. Retrieved 2020-01-04.
  28. ↑ "Prix Betty-Havens 2013 de l'application des connaissances de l'Institut du vieillissement des IRSC pour Dre Cara Tannenbaum - Département de médecine - Université de Montréal". Département de médecine (in French). 2013-08-20. Retrieved 2020-01-04.
  29. ↑ "Society of Chemical Industry - Purvis Memorial Award". www.soci.org. Retrieved 2022-01-08.
  30. ↑ "ASCPT Awards". www.ascpt.org. Retrieved 2022-01-08.
  31. ↑ "Two dozen Quebecers appointed to the Order of Canada". montrealgazette. Retrieved 2022-01-08.
  32. ↑ Tannenbaum, Cara; Bekker, Sheree (2019-03-20). "Sex, gender, and sports". BMJ. 364: l1120. doi:10.1136/bmj.l1120. ISSN   0959-8138. PMID   30894351. S2CID   84843710.
  33. ↑ "article". nouvelles.umontreal.ca. 2019-07-15. Retrieved 2020-01-04.
  34. ↑ "Sex and gender in science: why they matter". nouvelles.umontreal.ca. 2019-07-15. Archived from the original on 2020-09-01. Retrieved 2020-01-04.
  35. ↑ Tannenbaum, Cara; Greaves, Lorraine; Graham, Ian D. (December 2016). "Why sex and gender matter in implementation research". BMC Medical Research Methodology. 16 (1): 145. doi: 10.1186/s12874-016-0247-7 . ISSN   1471-2288. PMC   5084413 . PMID   27788671.
  36. ↑ Lowrie, Morgan (2019-03-20). "Testosterone rule for female athletes is unscientific, Canadian researcher says". CTVNews. Retrieved 2020-01-04.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.